Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery

Kerling, Anne ; Toka, Okan ; Rüffer, André ; Müller, Hanna ; Habash, Sheeraz ; Weiss, Christel ; Dittrich, Sven ; Moosmann, Julia

In: BMC Pediatrics, 19 (2019), Nr. 57. pp. 1-11. ISSN 1471-2431

[img]
Preview
PDF, English - main document
Download (913kB) | Lizenz: Creative Commons LizenzvertragFirst experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery by Kerling, Anne ; Toka, Okan ; Rüffer, André ; Müller, Hanna ; Habash, Sheeraz ; Weiss, Christel ; Dittrich, Sven ; Moosmann, Julia underlies the terms of Creative Commons Attribution 4.0

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: Postoperative fluid management in critically ill neonates and infants with capillary leak syndrome (CLS) and extensive volume overload after cardiac surgery on cardiopulmonary bypass is challenging. CLS is often resistant to conventional diuretic therapy, aggravating the course of weaning from invasive ventilation, increasing length of stay on ICU and morbidity and mortality.

Methods: Tolvaptan (TLV, vasopressin type 2 receptor antagonist) was used as an additive diuretic in neonates and infants with CLS after cardiac surgery. Retrospective analysis of 25 patients with CLS including preoperative and postoperative parameters was performed. Multivariate regression analysis was performed to identify predictors for TLV response.

Results: Multivariate analysis identified urinary output during 24 h after TLV administration and mean blood pressure (BP) on day 2 of TLV treatment as predictors for TLV response (AUC = 0.956). Responder showed greater weight reduction (p < 0.0001), earlier weaning from ventilator during TLV (p = 0.0421) and shorter time in the ICU after TLV treatment (p = 0.0155). Serum sodium and serum osmolality increased significantly over time in all patients treated with TLV.

Conclusion: In neonates and infants with diuretic-refractory CLS after cardiac surgery, additional aquaretic therapy with TLV showed an increase in urinary output and reduction in bodyweight in patients classified as TLV responder. Increase in urinary output and mean BP on day 2 of treatment were strong predictors for TLV response.

Item Type: Article
Journal or Publication Title: BMC Pediatrics
Volume: 19
Number: 57
Publisher: BioMed Central
Place of Publication: London
Date Deposited: 01 Apr 2019 10:35
Date: 2019
ISSN: 1471-2431
Page Range: pp. 1-11
Faculties / Institutes: Medizinische Fakultät Mannheim > Medizinische Statistik, Biomathematik und Informationsverarbeitung
Subjects: 610 Medical sciences Medicine
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative